ProKidney (PROK) News Today $1.66 +0.01 (+0.61%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Hennion & Walsh Asset Management Inc. Buys New Stake in ProKidney Corp. (NASDAQ:PROK)Hennion & Walsh Asset Management Inc. purchased a new position in shares of ProKidney Corp. (NASDAQ:PROK - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 568,647 shares of the company's sJanuary 20 at 3:24 AM | marketbeat.comCautiously Optimistic: ProKidney’s Hold Rating Amid Accelerated Pathway and Trial DevelopmentsJanuary 16, 2025 | markets.businessinsider.comKuehn Law Encourages Investors of ProKidney Corp. to Contact Law FirmJanuary 7, 2025 | markets.businessinsider.comProKidney to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7, 2025 | markets.businessinsider.comGeode Capital Management LLC Grows Stock Position in ProKidney Corp. (NASDAQ:PROK)Geode Capital Management LLC boosted its stake in shares of ProKidney Corp. (NASDAQ:PROK - Free Report) by 102.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,203,934 shares of the company's stock afteJanuary 6, 2025 | marketbeat.comOne ProKidney Insider Raised Their Stake In The Previous YearJanuary 6, 2025 | finance.yahoo.comStories to Watch in 2025: Will ProKidney change its Winston-Salem plans after abandoning $458M Greensboro facility?January 2, 2025 | bizjournals.comProKidney (NASDAQ:PROK) Shares Gap Up - Still a Buy?ProKidney (NASDAQ:PROK) Shares Gap Up - Time to Buy?December 31, 2024 | marketbeat.comTBJ's Top 24 of '24: ProKidney backs out of Guilford deal, invests in W-S facilities (No. 4)December 30, 2024 | bizjournals.comProKidney (NASDAQ:PROK) Shares Down 2.5% - What's Next?ProKidney (NASDAQ:PROK) Shares Down 2.5% - What's Next?December 26, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Stock Price Up 6.2% - Should You Buy?ProKidney (NASDAQ:PROK) Stock Price Up 6.2% - Time to Buy?December 24, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Gap Up - Here's What HappenedProKidney (NASDAQ:PROK) Shares Gap Up - Here's WhyDecember 23, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Down 4.8% - Here's What HappenedProKidney (NASDAQ:PROK) Stock Price Down 4.8% - Here's WhyDecember 18, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Raises Stock Holdings in ProKidney Corp. (NASDAQ:PROK)Charles Schwab Investment Management Inc. grew its stake in ProKidney Corp. (NASDAQ:PROK - Free Report) by 150.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 749,718 shares of the company's stock afteDecember 17, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Stock Price Up 5.9% - What's Next?ProKidney (NASDAQ:PROK) Stock Price Up 5.9% - Time to Buy?December 16, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Trading 8.4% Higher - What's Next?ProKidney (NASDAQ:PROK) Trading 8.4% Higher - Still a Buy?December 6, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Trading 5.4% Higher - Time to Buy?ProKidney (NASDAQ:PROK) Stock Price Up 5.4% - Here's What HappenedNovember 29, 2024 | marketbeat.comProKidney Corp. (NASDAQ:PROK) Shares Acquired by Suvretta Capital Management LLCSuvretta Capital Management LLC lifted its holdings in ProKidney Corp. (NASDAQ:PROK - Free Report) by 32.1% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 12,341,266 shares of the company's stock after purchasing an additional 3,000,000November 29, 2024 | marketbeat.comUS Penny Stocks To Watch: 3 Picks With Market Caps Under $500MNovember 26, 2024 | finance.yahoo.comProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare ConferenceNovember 26, 2024 | globenewswire.comProKidney purchases former Collins Aerospace facility, own HQ for $22.5MNovember 24, 2024 | bizjournals.comProKidney no longer coming to Greensboro, Chamber of Commerce confirmsNovember 21, 2024 | msn.comProKidney: Manufacturing expansion moving to W-S instead of GreensboroNovember 21, 2024 | bizjournals.comProKidney lists Greensboro property for sale, leaving future in city uncertainNovember 19, 2024 | msn.comFuture of development project promising hundreds of job now uncertainNovember 19, 2024 | msn.comProKidney lists building where it planned $458M investment for saleNovember 18, 2024 | bizjournals.comPharma company to expand Broward headquartersNovember 15, 2024 | bizjournals.comProKidney’s Progress in FDA Approval and Financial HealthNovember 13, 2024 | markets.businessinsider.comProKidney’s Future: Balancing Promising FDA Developments with Financial UncertaintiesNovember 13, 2024 | markets.businessinsider.comProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B MeetingNovember 12, 2024 | globenewswire.comTriad's public companies have gained millions in value since electionNovember 12, 2024 | bizjournals.comProKidney (NASDAQ:PROK) Stock, Option ChainNovember 9, 2024 | benzinga.comProKidney: Major Catalyst Is Too Far AwayNovember 7, 2024 | seekingalpha.comProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare ConferenceNovember 5, 2024 | globenewswire.comPower 50 Five to Watch: Bruce Culleton, ProKidneyOctober 23, 2024 | bizjournals.comWe're Not Very Worried About ProKidney's (NASDAQ:PROK) Cash Burn RateOctober 18, 2024 | finance.yahoo.comProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2024October 15, 2024 | markets.businessinsider.comProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024October 14, 2024 | globenewswire.comProKidney to Participate in the UBS Virtual Organ Restoration DayOctober 9, 2024 | globenewswire.comProKidney (NASDAQ:PROK) Stock Quotes, Forecast and News SummaryOctober 8, 2024 | benzinga.comJP Morgan Initiates Coverage of ProKidney (PROK) with Neutral RecommendationOctober 1, 2024 | msn.comMaintaining Hold on ProKidney: Balancing Potential Against Need for Further Efficacy DataSeptember 30, 2024 | markets.businessinsider.comProKidney (NASDAQ:PROK) Coverage Initiated by Analysts at JPMorgan Chase & Co.JPMorgan Chase & Co. started coverage on shares of ProKidney in a research report on Monday. They issued a "neutral" rating for the company.September 30, 2024 | marketbeat.comGlobal Corporate Wellness Market to Surpass ~USD 117 Billion by 2030 | DelveInsightSeptember 23, 2024 | finance.yahoo.comArch Biopartners Inc. (ARCH.V) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comInsider Selling: ProKidney Corp. (NASDAQ:PROK) Insider Sells 16,412 Shares of StockSeptember 21, 2024 | insidertrades.comProKidney Corp. (NASDAQ:PROK) Insider Darin J. Weber Sells 16,412 SharesProKidney Corp. (NASDAQ:PROK - Get Free Report) insider Darin J. Weber sold 16,412 shares of the company's stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $2.50, for a total transaction of $41,030.00. Following the completion of the transaction, the insider now owns 103,480 shares in the company, valued at approximately $258,700. The sale was disclosed in a legal filing with the SEC, which is available through this link.September 20, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Stock Price Down 6.7%ProKidney (NASDAQ:PROK) Stock Price Down 6.7%September 20, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Down 3.3% ProKidney (NASDAQ:PROK) Shares Down 3.3%September 12, 2024 | marketbeat.comBuy Rating on ProKidney: Promising Prospects in Chronic Kidney Disease TreatmentSeptember 11, 2024 | markets.businessinsider.com Get ProKidney News Delivered to You Automatically Sign up to receive the latest news and ratings for PROK and its competitors with MarketBeat's FREE daily newsletter. Email Address PROK Media Mentions By Week PROK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PROK News Sentiment▼1.240.48▲Average Medical News Sentiment PROK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PROK Articles This Week▼22▲PROK Articles Average Week Get ProKidney News Delivered to You Automatically Sign up to receive the latest news and ratings for PROK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies APGE News AMPH News TARS News IOVA News IRON News IBRX News WVE News BLTE News GLPG News ARQT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PROK) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProKidney Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProKidney With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PROK Stock Alerts